These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 677861)

  • 21. Piperacillin: evaluation against inpatient and gentamicin-resistant bacteria.
    Rosenthal SL; Freundlich LF; Rendler S; Winn R; Japko LI
    Scand J Infect Dis; 1980; 12(2):136-8. PubMed ID: 6445587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
    Kurtz TO; Winston DJ; Hindler JA; Young LS; Hewitt WL; Martin WJ
    Antimicrob Agents Chemother; 1980 Oct; 18(4):645-8. PubMed ID: 6255864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new pencillin with anti-klebsiella activity: 3-(5-tetrazolyl) penam.
    Bodey GP; Weaver S; Pan T
    J Antibiot (Tokyo); 1977 Sep; 30(9):724-9. PubMed ID: 924895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Jun; 21(6):906-11. PubMed ID: 6981375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of mezlocillin, piperacillin, Bay k 4999 with carbenicillin and ticarcillin against enterobacteriaceae and Pseudomonas aeruginosa.
    Sobel JD; Levison ME; Kaye D
    Infection; 1980; 8(3):121-2. PubMed ID: 6448229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility of anaerobic bacteria to 23 antimicrobial agents.
    Sutter VL; Finegold SM
    Antimicrob Agents Chemother; 1976 Oct; 10(4):736-52. PubMed ID: 984809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative in vitro activity of LY 127935 (6059-S), seven cephalosporins, three aminoglycosides, carbenicillin, and ticarcillin.
    Watanakunakorn C; Glotzbecker C
    J Antibiot (Tokyo); 1979 Oct; 32(10):1019-24. PubMed ID: 528361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro studies of alpha-carboxyl-3-thienylmethyl penicillin, a new semisynthetic penicillin.
    Bodey GP; Deerhake B
    Appl Microbiol; 1971 Jan; 21(1):61-5. PubMed ID: 4924999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH; Opfer BJ; Gerding DN
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro inactivation of aminoglycoside antibiotics by piperacillin and carbenicillin.
    Hale DC; Jenkins R; Matsen JM
    Am J Clin Pathol; 1980 Sep; 74(3):316-9. PubMed ID: 6447998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evaluation of the in vitro activity of piperacillin/tazobactam.
    Daley D; Mulgrave L; Munro R; Neville S; Smith H; Dimech W
    Pathology; 1996 May; 28(2):167-72. PubMed ID: 8743825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
    Høiby N; Bremmelgaard A; Schouenborg P
    Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation of piperacillin in vitro.
    Dickinson GM; Cleary TJ; Hoffman TA
    Antimicrob Agents Chemother; 1978 Dec; 14(6):919-21. PubMed ID: 253573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of LY127935, a new 1-oxa cephalosporin, against aerobic gram-negative bacilli.
    Delgado DG; Brau CJ; Cobbs CG; Dismukes WE
    Antimicrob Agents Chemother; 1979 Dec; 16(6):864-8. PubMed ID: 533267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosides.
    Barry AL; Thornsberry C; Jones RN; Gavan TL
    Cleve Clin Q; 1980; 47(4):311-9. PubMed ID: 6451334
    [No Abstract]   [Full Text] [Related]  

  • 37. Azlocillin and mezlocillin: new ureido penicillins.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1978 Jun; 13(6):930-8. PubMed ID: 677860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro evaluation of Ro 13-9904.
    Hinkle AM; Bodey GP
    Antimicrob Agents Chemother; 1980 Oct; 18(4):574-8. PubMed ID: 6778383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The comparative synergistic activity of amikacin, gentamicin, netilmicin and azlocillin, mezlocillin, carbenicillin and ticarcillin against Serratia marcescens.
    Fu KP; Neu HC
    J Antibiot (Tokyo); 1978 Feb; 31(2):135-40. PubMed ID: 344298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms.
    Dawis MA; Isenberg HD; France KA; Jenkins SG
    J Antimicrob Chemother; 2003 May; 51(5):1203-11. PubMed ID: 12697632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.